Apimeds Pharmaceuticals US, Inc. (APUS) › Total AssetsApimeds Pharmaceuticals US, Inc. (APUS) — Total AssetsAnnual figures by fiscal year, from SEC filings.2023: $422.1K2024: $13.1K2025: $164.18M$164.18M2023Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$164.18M+1257338.4%2024$13.1K-96.9%2023$422.1K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share